Cargando…
Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
Withdrawal symptoms after discontinuation of antidepressants are common and have long been known. Typical symptoms after dose reduction or discontinuation of antidepressants are dizziness, drowsiness, headache, flu-like symptoms, hyperarousal, imbalance, insomnia, irritability, and nausea. Rebound,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028703/ https://www.ncbi.nlm.nih.gov/pubmed/32116847 http://dx.doi.org/10.3389/fpsyt.2020.00032 |
_version_ | 1783499024512319488 |
---|---|
author | Gahr, Maximilian Hiemke, Christoph Kölle, Markus Alexander |
author_facet | Gahr, Maximilian Hiemke, Christoph Kölle, Markus Alexander |
author_sort | Gahr, Maximilian |
collection | PubMed |
description | Withdrawal symptoms after discontinuation of antidepressants are common and have long been known. Typical symptoms after dose reduction or discontinuation of antidepressants are dizziness, drowsiness, headache, flu-like symptoms, hyperarousal, imbalance, insomnia, irritability, and nausea. Rebound, relapse, or recurrence associated with the underlying mental disorder may also occur. The occurrence of obsessive-compulsive symptoms (OCS) following abrupt discontinuation of antidepressants have not yet been reported. Here we report the development of OCS (obsessional suicidal thoughts) in a patient with major depressive disorder and absence of a previous obsessive-compulsive disorder following abrupt discontinuation of venlafaxine. Treatment with escitalopram facilitated remission of OCS. We discuss a possible causal link between abrupt discontinuation of venlafaxine and development of OCS under consideration of pathophysiologic aspects regarding obsessive compulsive disorders, the chronological sequence of symptoms in the present case, and pharmacodynamic and -kinetic aspects. Our case report suggests the possibility of the occurrence of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine. |
format | Online Article Text |
id | pubmed-7028703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70287032020-02-28 Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine Gahr, Maximilian Hiemke, Christoph Kölle, Markus Alexander Front Psychiatry Psychiatry Withdrawal symptoms after discontinuation of antidepressants are common and have long been known. Typical symptoms after dose reduction or discontinuation of antidepressants are dizziness, drowsiness, headache, flu-like symptoms, hyperarousal, imbalance, insomnia, irritability, and nausea. Rebound, relapse, or recurrence associated with the underlying mental disorder may also occur. The occurrence of obsessive-compulsive symptoms (OCS) following abrupt discontinuation of antidepressants have not yet been reported. Here we report the development of OCS (obsessional suicidal thoughts) in a patient with major depressive disorder and absence of a previous obsessive-compulsive disorder following abrupt discontinuation of venlafaxine. Treatment with escitalopram facilitated remission of OCS. We discuss a possible causal link between abrupt discontinuation of venlafaxine and development of OCS under consideration of pathophysiologic aspects regarding obsessive compulsive disorders, the chronological sequence of symptoms in the present case, and pharmacodynamic and -kinetic aspects. Our case report suggests the possibility of the occurrence of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine. Frontiers Media S.A. 2020-02-12 /pmc/articles/PMC7028703/ /pubmed/32116847 http://dx.doi.org/10.3389/fpsyt.2020.00032 Text en Copyright © 2020 Gahr, Hiemke and Kölle http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Gahr, Maximilian Hiemke, Christoph Kölle, Markus Alexander Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine |
title | Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine |
title_full | Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine |
title_fullStr | Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine |
title_full_unstemmed | Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine |
title_short | Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine |
title_sort | development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028703/ https://www.ncbi.nlm.nih.gov/pubmed/32116847 http://dx.doi.org/10.3389/fpsyt.2020.00032 |
work_keys_str_mv | AT gahrmaximilian developmentofobsessivecompulsivesymptomsfollowingabruptdiscontinuationofvenlafaxine AT hiemkechristoph developmentofobsessivecompulsivesymptomsfollowingabruptdiscontinuationofvenlafaxine AT kollemarkusalexander developmentofobsessivecompulsivesymptomsfollowingabruptdiscontinuationofvenlafaxine |